BAX INVESTOR NOTICE: Baxter International Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law

Core Viewpoint - Baxter International, Inc. is facing a class action lawsuit due to allegations of misleading statements and undisclosed systemic defects in its Novum IQ Large Volume Pump, which have resulted in serious patient risks and a significant drop in stock price [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Electrical Workers Pension Fund, Local 103, I.B.E.W. v. Baxter International, Inc., and covers purchasers of Baxter common stock from February 23, 2022, to July 30, 2025 [1]. - Investors have until December 15, 2025, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit alleges that Baxter's Novum IQ Large Volume Pump had systemic defects leading to malfunctions that posed risks of serious injury or death to patients [3]. Group 2: Allegations Against Baxter - Baxter was reportedly aware of multiple device malfunctions, injuries, and deaths related to the Novum LVP but failed to adequately address these issues [3]. - On July 31, 2025, Baxter announced a voluntary and temporary pause in shipments and installations of the Novum LVP, which contributed to a more than 22% drop in the company's stock price [4]. Group 3: Legal Process and Representation - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Baxter common stock during the class period to seek lead plaintiff status [5]. - The lead plaintiff will represent the interests of all class members and can select a law firm of their choice for litigation [5]. Group 4: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading firm in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [6]. - The firm has been ranked 1 in securing monetary relief for investors in securities class action cases for four out of the last five years [6].